4-Week Lead-In With Nitazoxanide Followed by 36 Weeks Nitazoxanide and Peginterferon Alfa-2a in Chronic Hepatitis C
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if taking nitazoxanide alone for 4 weeks followed
by 36 weeks of nitazoxanide plus peginterferon is superior to peginterferon plus ribavirin
(standard of care) for 48 weeks.